Patient 195 was CK7+/CK20−, and the corresponding assembloid reflected this; patient 005 was heterogeneously positive for both CK7 and CK20, whereas the assembloid was mostly CK7+/CK20−, with a minority of CK7+/CK20+ tumor cells. This evidence concerns the gene KRT7 and neoplasm.